![](/images/general/no_picture/200_user.png)
Michael H Caley
Supervisory Patent Examiner (ID: 5376, Phone: (571)272-2286 , Office: P/2871 )
Most Active Art Unit | 2871 |
Art Unit(s) | 2871, 2882 |
Total Applications | 829 |
Issued Applications | 574 |
Pending Applications | 21 |
Abandoned Applications | 234 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6971693
[patent_doc_number] => 20050037403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Immunomodulatory oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 10/888089
[patent_app_country] => US
[patent_app_date] => 2004-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11234
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20050037403.pdf
[firstpage_image] =>[orig_patent_app_number] => 10888089
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/888089 | Immunomodulatory oligonucleotides | Jul 8, 2004 | Issued |
Array
(
[id] => 7089661
[patent_doc_number] => 20050009774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Immunomodulatory oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 10/888885
[patent_app_country] => US
[patent_app_date] => 2004-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11236
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20050009774.pdf
[firstpage_image] =>[orig_patent_app_number] => 10888885
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/888885 | Immunomodulatory oligonucleotides | Jul 8, 2004 | Abandoned |
Array
(
[id] => 173680
[patent_doc_number] => 07659059
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-09
[patent_title] => 'Method for detecting and/or identifying bacteria of the genus Staphylococcus'
[patent_app_type] => utility
[patent_app_number] => 10/560433
[patent_app_country] => US
[patent_app_date] => 2004-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7830
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/659/07659059.pdf
[firstpage_image] =>[orig_patent_app_number] => 10560433
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/560433 | Method for detecting and/or identifying bacteria of the genus Staphylococcus | Jul 7, 2004 | Issued |
Array
(
[id] => 5687813
[patent_doc_number] => 20060286128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Adjuvant combinations of liposomes and mycobacteriaial lipids for immunization compositions and vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/563731
[patent_app_country] => US
[patent_app_date] => 2004-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12093
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20060286128.pdf
[firstpage_image] =>[orig_patent_app_number] => 10563731
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/563731 | Adjuvant combinations of liposomes and mycobacteriaial lipids for immunization compositions and vaccines | Jul 6, 2004 | Abandoned |
Array
(
[id] => 5034200
[patent_doc_number] => 20070098739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Vaccine compositions for vaccinating dogs against canine infectious respiratory disease'
[patent_app_type] => utility
[patent_app_number] => 10/563199
[patent_app_country] => US
[patent_app_date] => 2004-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18854
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20070098739.pdf
[firstpage_image] =>[orig_patent_app_number] => 10563199
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/563199 | Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD) | Jun 30, 2004 | Issued |
Array
(
[id] => 7689529
[patent_doc_number] => 20070105169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Secreted polypeptide species associated with cardiovascular disorders'
[patent_app_type] => utility
[patent_app_number] => 10/561292
[patent_app_country] => US
[patent_app_date] => 2004-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 46132
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105169.pdf
[firstpage_image] =>[orig_patent_app_number] => 10561292
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/561292 | Secreted polypeptide species associated with cardiovascular disorders | Jun 28, 2004 | Abandoned |
Array
(
[id] => 7263389
[patent_doc_number] => 20040241689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Antigens of and antibodies to translocated molecules of microorganisms and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/485002
[patent_app_country] => US
[patent_app_date] => 2004-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 19226
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241689.pdf
[firstpage_image] =>[orig_patent_app_number] => 10485002
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/485002 | Antigens of and antibodies to translocated molecules of microorganisms and uses thereof | Jun 27, 2004 | Abandoned |
Array
(
[id] => 177705
[patent_doc_number] => 07655413
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-02
[patent_title] => 'Methods and compositions for enhanced protein expression and purification'
[patent_app_type] => utility
[patent_app_number] => 10/504785
[patent_app_country] => US
[patent_app_date] => 2004-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 19257
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/655/07655413.pdf
[firstpage_image] =>[orig_patent_app_number] => 10504785
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/504785 | Methods and compositions for enhanced protein expression and purification | Jun 27, 2004 | Issued |
Array
(
[id] => 7276327
[patent_doc_number] => 20040235778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Methods for regulating hematopoiesis using CpG-oligonucleotides'
[patent_app_type] => new
[patent_app_number] => 10/876965
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 26437
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235778.pdf
[firstpage_image] =>[orig_patent_app_number] => 10876965
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/876965 | Methods for regulating hematopoiesis using CpG-oligonucleotides | Jun 24, 2004 | Abandoned |
Array
(
[id] => 5141771
[patent_doc_number] => 20070003987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Screening method for substance binding to merozoite surface protein-1/42'
[patent_app_type] => utility
[patent_app_number] => 10/561196
[patent_app_country] => US
[patent_app_date] => 2004-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 8666
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20070003987.pdf
[firstpage_image] =>[orig_patent_app_number] => 10561196
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/561196 | Screening method for substance binding to merozoite surface protein-1/42 | Jun 17, 2004 | Abandoned |
Array
(
[id] => 7026545
[patent_doc_number] => 20050020516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Effects of combined administration of farnesyl transferase inhibitors and signal transduction inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/870403
[patent_app_country] => US
[patent_app_date] => 2004-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5250
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20050020516.pdf
[firstpage_image] =>[orig_patent_app_number] => 10870403
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/870403 | Effects of combined administration of farnesyl transferase inhibitors and signal transduction inhibitors | Jun 16, 2004 | Abandoned |
Array
(
[id] => 4629381
[patent_doc_number] => 08008267
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-30
[patent_title] => 'Stabilized immunomodulatory oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 10/865245
[patent_app_country] => US
[patent_app_date] => 2004-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16461
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 362
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/008/08008267.pdf
[firstpage_image] =>[orig_patent_app_number] => 10865245
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/865245 | Stabilized immunomodulatory oligonucleotides | Jun 9, 2004 | Issued |
Array
(
[id] => 7341114
[patent_doc_number] => 20040191170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Animal model for enteric pathogens'
[patent_app_type] => new
[patent_app_number] => 10/473735
[patent_app_country] => US
[patent_app_date] => 2004-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7224
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20040191170.pdf
[firstpage_image] =>[orig_patent_app_number] => 10473735
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/473735 | Animal model for enteric pathogens | Jun 2, 2004 | Abandoned |
Array
(
[id] => 7424762
[patent_doc_number] => 20040208889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Pharmaceutical use for secreted bacterial effector proteins'
[patent_app_type] => new
[patent_app_number] => 10/478516
[patent_app_country] => US
[patent_app_date] => 2004-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13622
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20040208889.pdf
[firstpage_image] =>[orig_patent_app_number] => 10478516
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/478516 | Pharmaceutical use for secreted bacterial effector proteins | May 25, 2004 | Abandoned |
Array
(
[id] => 7061700
[patent_doc_number] => 20050004062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Immunomodulatory oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 10/847650
[patent_app_country] => US
[patent_app_date] => 2004-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11244
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20050004062.pdf
[firstpage_image] =>[orig_patent_app_number] => 10847650
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/847650 | Immunomodulatory oligonucleotides | May 16, 2004 | Abandoned |
Array
(
[id] => 289147
[patent_doc_number] => 07547762
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-16
[patent_title] => 'T24 antigen for immunodiagnosis of Taenia solium cysticercosis'
[patent_app_type] => utility
[patent_app_number] => 10/557265
[patent_app_country] => US
[patent_app_date] => 2004-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 25936
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/547/07547762.pdf
[firstpage_image] =>[orig_patent_app_number] => 10557265
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/557265 | T24 antigen for immunodiagnosis of Taenia solium cysticercosis | May 12, 2004 | Issued |
Array
(
[id] => 7176211
[patent_doc_number] => 20050123550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Molecules enhancing dermal delivery of influenza vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/842922
[patent_app_country] => US
[patent_app_date] => 2004-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 34218
[patent_no_of_claims] => 94
[patent_no_of_ind_claims] => 44
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123550.pdf
[firstpage_image] =>[orig_patent_app_number] => 10842922
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/842922 | Molecules enhancing dermal delivery of influenza vaccines | May 9, 2004 | Abandoned |
Array
(
[id] => 4533749
[patent_doc_number] => 07871984
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-18
[patent_title] => 'Methylated CpG polynucleotide'
[patent_app_type] => utility
[patent_app_number] => 10/553948
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2961
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/871/07871984.pdf
[firstpage_image] =>[orig_patent_app_number] => 10553948
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/553948 | Methylated CpG polynucleotide | Apr 22, 2004 | Issued |
Array
(
[id] => 7010735
[patent_doc_number] => 20050064451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Methods and compositions for the detection of bacterial species'
[patent_app_type] => utility
[patent_app_number] => 10/820971
[patent_app_country] => US
[patent_app_date] => 2004-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15007
[patent_no_of_claims] => 105
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20050064451.pdf
[firstpage_image] =>[orig_patent_app_number] => 10820971
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/820971 | Methods and compositions for the detection of bacterial species | Apr 7, 2004 | Abandoned |
Array
(
[id] => 7263864
[patent_doc_number] => 20040241831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'tdcBC/pckA gene-inactivated microorganism and method of producing L-threonine using the same'
[patent_app_type] => new
[patent_app_number] => 10/817044
[patent_app_country] => US
[patent_app_date] => 2004-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4867
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241831.pdf
[firstpage_image] =>[orig_patent_app_number] => 10817044
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/817044 | tdcBC/pckA gene-inactivated microorganism and method of producing L-threonine using the same | Apr 1, 2004 | Issued |